Equity Research, Broker Reports, and media content on Synairgen plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Synairgen plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Synairgen plc

Company Profile

  • Personnel
  • Richard J Marsden, CEO
  • John C Ward, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Synairgen plc. We currently have 101 research reports from 5 professional analysts.

  • Open: 160p
  • Range Today: 145/160p
  • 52 Week: 32.6/258p
  • Daily Volume: 1.8m
  • Daily Liquidity: (1.23%)
  • # Shares: 149.4m
  • Market Cap: £298.6m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
06Apr21 16:36 RNS Holding(s) in Company
15Feb21 07:00 RNS Dosing commenced in US ACTIV-2 trial
25Jan21 07:00 RNS Inclusion in US ACTIV-2 trial
20Jan21 07:00 RNS Home trial recruitment completed
13Jan21 07:00 RNS First Patient Dosing in Phase III SG018 Trial
06Jan21 17:10 RNS Holding(s) in Company
05Jan21 17:53 RNS Holding(s) in Company
  • Frequency of research reports

     

  • Research reports on

    Synairgen plc

  • Providers covering

    Synairgen plc